Autopsy report · NCT07181720
CD70-Targeted CAR-T Therapy in CD70-Positive Advanced Solid Tumors
Cause of deathFunding or business
“Sponsor stopped the study.”
Life of this trial
- Suspended: paused, and may or may not restart.
- 90 participants planned (an estimate, not an actual count).
Vital statistics
- Status
- Suspended
- Phase
- Phase 1
- Sponsor
- Chongqing Precision Biotech Co., Ltd
- Sponsor type
- Industry
- Conditions
- Renal Cell Carcinoma (RCC); Lung Cancer; Anaplastic Thyroid Carcinomas; Ovarian Cancer; Cervical Cancer; Thymic Carcinoma
- Interventions
- CD70-targeted CAR-T cells; CD70-targeted CAR-T cells; CD70-targeted CAR-T cells
- Participants
- 90 (planned, not actual)
- Sites
- 1
- Countries
- China
Trials that died the same way
- Association Between Cancer Cells and Normal Versus (Vs.) Low Levels of Thyroid Hormones in the Serum
“The sponsor stopped the study.” - the Health Crisis at the Healthcare Professionals, Careers and Non-careers, a Month After the Containment Period
“the sponsor decided to stop the study” - Safety Study of Intranasal Etripamil for the Termination of Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia (PSVT). NODE-302
“Study was stopped by the Sponsor” - Multi-center Complex Atrial Tachycardia High-Resolution Mapping Registry (MATH)
“The sponsor has decided to stop the study” - Study to Evaluate the Efficacy and Safety of Armodafinil as Treatment for Patients With Excessive Sleepiness Associated With Mild or Moderate Closed Traumatic Brain Injury
“Study has been stopped by sponsor decision.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.